Skip to content

Clinical trials

Phase 3 Ischemic Stroke trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 3 Country / region: Taiwan Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20122
20182
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chang Gung Memorial Hospital2
Boehringer Ingelheim1
CSL Behring1
H. Lundbeck A/S1
Healios K.K.1
Janssen Research & Development, LLC1
Neuroscience Trials Australia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke8
Stroke3
Acute Coronary Syndrome1
Atherosclerosis1
Atrial Fibrillation1
Cardiovascular Diseases1
Coronary Artery Disease1
Dehydration1
Heart Diseases1
Heart Failure1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.